Sign In
Buy KDMN
$9.50
+0 (+0%)
At Close: Aug 17, 2022
Sanofi (SNY) to Buy Kadmon for $1.9B, Add cGVHD Drug Rezurock
11:00am, Wednesday, 08'th Sep 2021
Sanofi (SNY) offers $1.9 billion to buy Kadmon Holdings to strengthen its transplant business.
Why Kadmon Holdings Stock Is Rocketing Higher Today
08:38am, Wednesday, 08'th Sep 2021
Sanofi adds another bolt-on acquisition in what is turning out to be a busy year for the French pharma titan.
Sanofi to acquire Kadmon to further strengthen growth of transplant business
08:08am, Wednesday, 08'th Sep 2021
Dear recipient,Please note this is a corrected french version of the release which replaces the release sent on September 8 at 8.31 am Paris time where the word « … relutif» has been replaced wit
Kadmon Stock Soars as Sanofi Buys U.S. Biotech for $1.9 Billion
07:54am, Wednesday, 08'th Sep 2021
French drugmaker Sanofi is buying Kadmon, the U.S. biopharmaceutical company, for a total equity value of $1.9 billion.
Sanofi's $1.9 Billion Bet On Kadmon: What You Need to Know
06:30am, Wednesday, 08'th Sep 2021
Underlining the focus on inorganic growth, French pharma giant Sanofi (NASDAQ: SNY) announced a big-ticket acquisition just a month after another billion-dollar deal. Sanofi-Kadmon Deal Terms: Sano
KDMN Stock: Over 75% Stock Increase Pre-Market Explanation
06:04am, Wednesday, 08'th Sep 2021
The stock price of Kadmon Holdings Inc (NASDAQ: KDMN) increased by over 75% pre-market. This is why it happened.
Sanofi to acquire U.S. biopharmaceutical group Kadmon in $1.9 billion deal
01:31am, Wednesday, 08'th Sep 2021
French pharmaceutical major Sanofi SA said Wednesday that it has entered into a definitive agreement to acquire U.S.-based biopharmaceutical company Kadmon Holdings Inc.
France's Sanofi to buy U.S. biopharma firm Kadmon in $1.9 billion deal
01:15am, Wednesday, 08'th Sep 2021
French drugmaker Sanofi SA has agreed to buy U.S. biopharmaceutical company Kadmon Holdings Inc in a $1.9 billion deal, the companies said on Wednesday.
Sanofi To Acquire Kadmon To Further Strengthen Growth of Transplant Business
01:00am, Wednesday, 08'th Sep 2021
Adds Rezurock™ (belumosudil) an FDA-approved, first-in-class treatment for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (cGVHD) after failure of at least tw
NEW YORK, NY / ACCESSWIRE / August 19, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced that REZUROCK™ (belumosudil) 200 mg once daily (QD) tablets is now commercially available for shipme
5 Penny Stocks Analysts Say To Buy With Targets Up To 300%
11:41am, Wednesday, 18'th Aug 2021
Penny stocks to buy according to analysts with price targets up to 300% right now. The post 5 Penny Stocks Analysts Say To Buy With Targets Up To 300% appeared first on Penny Stocks to Buy, Picks, New
Implied Volatility Surging for Kadmon Holdings (KDMN) Stock Options
11:47am, Wednesday, 11'th Aug 2021
Investors need to pay close attention to Kadmon Holdings (KDMN) stock based on the movements in the options market lately.
Kadmon Holdings, Inc. (KDMN) Reports Q2 Loss, Lags Revenue Estimates
09:17pm, Thursday, 05'th Aug 2021
Kadmon Holdings, Inc. (KDMN) delivered earnings and revenue surprises of 0.00% and -42.06%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Kadmon Provides Business Update and Reports Second Quarter 2021 Financial Results
04:05pm, Thursday, 05'th Aug 2021
NEW YORK, NY / ACCESSWIRE / August 5, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today provided a business update and reported financial and operational results for the second quarter of 2021. "The re
Kadmon: What Will Lead To A Short Squeeze
02:46am, Monday, 02'nd Aug 2021
Despite an approval, Kadmon hasn't done as well as it should. The criminal pasts of its founders have been used as a way to keep it down.
